Corrigendum: Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Bibliographic Details
Title: Corrigendum: Improvement of Sepsis Prognosis by Ulinastatin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Authors: Wang, Huifang, Liu, Bin, Tang, Ying, Chang, Ping, Yao, Lishuai, Huang, Bo, Lodato, Robert F., Liu, Zhanguo
Source: Frontiers in Pharmacology; 2/21/2020, p1-4, 4p
Subject Terms: RANDOMIZED controlled trials, SEPSIS, META-analysis
Abstract: In the abstract, "(MD = -88.5, 95% CI [-123.97,-53.04], p < 0.00001)" of IL-6 were changed to "MD = -53.00, 95% CI [-95.56, -10.05], p = 0.02." "95% confidence interval (CI) [0.35-0.66]" of all-cause mortality was changed to "95% confidence interval (CI) [0.35, 0.66]". "mean difference (MD) = -2.40, 95% CI [-4.37, -0.44], p = 0.02, I SP 2 sp = 66%" of APACHE II score was changed to "mean difference (MD) = -3.18, 95% CI [-4.01, -2.35], p < 0.00001, I SP 2 sp = 33%". In the subsection of I Levels of TNF-a i , "MD = -56.22, 95% CI [-72.11, -40.33], p < 0.00001" was changed to "MD = -53.05, 95%CI [-68.36,-37.73], p < 0.00001"; "x SP 2 sp = 47.26, p < 0.00001, I SP 2 sp = 81%" was changed to "x SP 2 sp = 43.58, p < 0.00001, I SP 2 sp = 79%.". [Extracted from the article]
Copyright of Frontiers in Pharmacology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:16639812
DOI:10.3389/fphar.2019.01697
Published in:Frontiers in Pharmacology
Language:English